These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 15182912
1. Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. Russo EB, Merzouki A, Mesa JM, Frey KA, Bach PJ. J Ethnopharmacol; 2004 Jul; 93(1):99-104. PubMed ID: 15182912 [Abstract] [Full Text] [Related]
2. The effect of anthocyanosides on night vision. Levy Y, Glovinsky Y. Eye (Lond); 1998 Jul; 12 ( Pt 6)():967-9. PubMed ID: 10325997 [Abstract] [Full Text] [Related]
3. Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease. Kiser AK, Mladenovich D, Eshraghi F, Bourdeau D, Dagnelie G. Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):444-52. PubMed ID: 16384995 [Abstract] [Full Text] [Related]
4. The effect of anthocyanosides in a multiple oral dose on night vision. Zadok D, Levy Y, Glovinsky Y. Eye (Lond); 1999 Dec; 13 ( Pt 6)():734-6. PubMed ID: 10707135 [Abstract] [Full Text] [Related]
5. Concerning kif, a Cannabis sativa L. preparation smoked in the Rif mountains of northern Morocco. Merzouki A, Mesa JM. J Ethnopharmacol; 2002 Aug; 81(3):403-6. PubMed ID: 12127244 [Abstract] [Full Text] [Related]
6. Evaluation of mid-term stability of night vision tests. Levy Y, Glovinsky Y. Aviat Space Environ Med; 1997 Jul; 68(7):565-8. PubMed ID: 9215460 [Abstract] [Full Text] [Related]
7. Assessing changes in pupillary size in Rifian smokers of kif (Cannabis sativa L.). Merzouki A, Molero Mesa J, Louktibi A, Kadiri M, Urbano GV. J Forensic Leg Med; 2008 Jul; 15(5):335-8. PubMed ID: 18511011 [Abstract] [Full Text] [Related]
8. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. Cannabis-In-Cachexia-Study-GroupDivision of Oncology/Hematology, Department of Internal Medicine, Cantonal Hospital, St Gallen, Switzerland. florian.strasser@kssg.ch, Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T. J Clin Oncol; 2006 Jul 20; 24(21):3394-400. PubMed ID: 16849753 [Abstract] [Full Text] [Related]
9. Is color vision deficiency an advantage under scotopic conditions? Simunovic MP, Regan BC, Mollon JD. Invest Ophthalmol Vis Sci; 2001 Dec 20; 42(13):3357-64. PubMed ID: 11726645 [Abstract] [Full Text] [Related]
10. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR. J Psychopharmacol; 2009 May 20; 23(3):266-77. PubMed ID: 18719045 [Abstract] [Full Text] [Related]
11. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. Verhoeckx KC, Korthout HA, van Meeteren-Kreikamp AP, Ehlert KA, Wang M, van der Greef J, Rodenburg RJ, Witkamp RF. Int Immunopharmacol; 2006 Apr 20; 6(4):656-65. PubMed ID: 16504929 [Abstract] [Full Text] [Related]
12. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Drug Alcohol Depend; 2007 Jan 05; 86(1):22-9. PubMed ID: 16769180 [Abstract] [Full Text] [Related]
13. The Scotopic Sensitivity Tester-1 and the detection of early age-related macular degeneration. Jackson GR, Felix T, Owsley C. Ophthalmic Physiol Opt; 2006 Jul 05; 26(4):431-7. PubMed ID: 16792744 [Abstract] [Full Text] [Related]
14. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I. Anesthesiology; 2007 Nov 05; 107(5):785-96. PubMed ID: 18073554 [Abstract] [Full Text] [Related]
15. Effect of intrapulmonary tetrahydrocannabinol administration in humans. Zuurman L, Roy C, Schoemaker RC, Hazekamp A, den Hartigh J, Bender JC, Verpoorte R, Pinquier JL, Cohen AF, van Gerven JM. J Psychopharmacol; 2008 Sep 05; 22(7):707-16. PubMed ID: 18515447 [Abstract] [Full Text] [Related]
16. Marijuana and vision--after ten years' use in Costa Rica. Dawson WW, Jiménez-Antillon CF, Perez JM, Zeskind JA. Invest Ophthalmol Vis Sci; 1977 Aug 05; 16(8):689-99. PubMed ID: 885679 [Abstract] [Full Text] [Related]
17. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Roman AJ, Schwartz SB, Aleman TS, Cideciyan AV, Chico JD, Windsor EA, Gardner LM, Ying GS, Smilko EE, Maguire MG, Jacobson SG. Exp Eye Res; 2005 Feb 05; 80(2):259-72. PubMed ID: 15670804 [Abstract] [Full Text] [Related]
18. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM. Eur Neuropsychopharmacol; 2008 Aug 05; 18(8):569-77. PubMed ID: 18544469 [Abstract] [Full Text] [Related]
19. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood. Papafotiou K, Carter JD, Stough C. Forensic Sci Int; 2005 Dec 20; 155(2-3):172-8. PubMed ID: 16226154 [Abstract] [Full Text] [Related]
20. Kif in Morocco. Nahas GG, Zeidenberg P, Lefebure C. Int J Addict; 1975 Dec 20; 10(6):977-93. PubMed ID: 1104494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]